These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36907105)

  • 21. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.
    Lee SJ; Lee I; Lee J; Park C; Kang WK
    Br J Cancer; 2014 Jul; 111(3):497-505. PubMed ID: 24945998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
    Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
    Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential use of simvastatin for cancer treatment: A review.
    Duarte JA; de Barros ALB; Leite EA
    Biomed Pharmacother; 2021 Sep; 141():111858. PubMed ID: 34323700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
    Koyuturk M; Ersoz M; Altiok N
    Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
    Zhang R; Banik NL; Ray SK
    Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells.
    Gergen AK; Kohtz PD; Halpern AL; White AM; Meng X; Fullerton DA; Weyant MJ
    J Surg Res; 2021 Apr; 260():436-447. PubMed ID: 33272595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastatin reduces melanoma progression in a murine model.
    Zanfardino M; Spampanato C; De Cicco R; Buommino E; De Filippis A; Baiano S; Barra A; Morelli F
    Int J Oncol; 2013 Dec; 43(6):1763-70. PubMed ID: 24101161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin.
    Misirkic M; Janjetovic K; Vucicevic L; Tovilovic G; Ristic B; Vilimanovich U; Harhaji-Trajkovic L; Sumarac-Dumanovic M; Micic D; Bumbasirevic V; Trajkovic V
    Pharmacol Res; 2012 Jan; 65(1):111-9. PubMed ID: 21871960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.
    Pelaia G; Gallelli L; Renda T; Fratto D; Falcone D; Caraglia M; Busceti MT; Terracciano R; Vatrella A; Maselli R; Savino R
    Cell Prolif; 2012 Dec; 45(6):557-65. PubMed ID: 23045963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR; Wang SL; Wang M; Sun LM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
    Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
    Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
    Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
    Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and simvastatin synergistically suppress endothelin 1-induced hypoxia and angiogenesis in multiple cancer types.
    Liu J; Wang H; Zhang M; Li Y; Wang R; Chen H; Wang B; Gao X; Song S; Wang Y; Ren Y; Li J; Liu P
    Cancer Sci; 2023 Feb; 114(2):640-653. PubMed ID: 36156330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.
    Babcook MA; Shukla S; Fu P; Vazquez EJ; Puchowicz MA; Molter JP; Oak CZ; MacLennan GT; Flask CA; Lindner DJ; Parker Y; Daneshgari F; Gupta S
    Mol Cancer Ther; 2014 Oct; 13(10):2288-302. PubMed ID: 25122066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
    Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
    Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.